High dose of vitamin D fails to improve condition of moderate to severe COVID-19 patients Hina Zahid24 April 2021 7:15 AM ISTAgencia FAPESP - Can a high dose of vitamin D administered on admission to hospital improve the condition of patients with moderate or severe...
Athletes unlikely to develop cardiac complications from COVID, study shows Hina Zahid19 April 2021 7:15 AM ISTDALLAS - While the lasting impact of COVID-19 on hospitalized patients in the general population is common and associated with adverse cardiac...
Patients who are overweight or obese at risk of more severe COVID-19 Hina Zahid16 April 2021 8:30 AM ISTPatients who are overweight or obese have more severe COVID-19 and are highly likely to require invasive respiratory support, according to a new...
Patients with previous COVID-19, at 84 percent lower risk of reinfection: Lancet Medha Baranwal15 April 2021 7:45 AM ISTUK: A previous history of COVID-19 cuts the risk of reinfection by 84% and also lowers the risk of symptomatic infection during 7 months of follow-up...
Case of Guillain-Barre syndrome reported after COVID 19 Vaccination- a report MD Bureau14 April 2021 6:15 AM ISTA recent case report demonstrated a patient who developed Guillain-Barre syndrome (GBS) in the 19 Vaccine trial. The case report also recorded an...
Serum Institute secures CDSCO panel nod for bridge trial of Novavax Covid-19 vaccine Medical Dialogues Team18 March 2021 4:48 PM ISTNew Delhi: In order to tackle the Covid-19 upsurge, the Subject Expert Committee (SEC) committee functional under the Central Drugs Standard Control...
SARS-CoV-2, Dysbiosis and Potential Role of Probiotics hina2 March 2021 12:45 PM ISTThe ongoing global pandemic of COVID-19 caused by novel SARS-CoV-2 has been identified as a highly contagious and infectious disease mainly...
FDA Issues Emergency Use Authorization for Janssen's COVID-19 Vaccine Hina Zahid1 March 2021 6:09 PM ISTThe U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019...
COVID 19 leading to diabetes in India? Researchers throw light Medha Baranwal18 Feb 2021 7:15 PM ISTMaharashtra, India: The researchers from India have found a new trend to be prevalent in India -- coronavirus infection is leading to the onset of...
PPI exposure worsens clinical outcomes , increases mortality in COVID-19 patients MD Bureau15 Dec 2020 2:02 PM ISTA recent study published in the European Journal of Gastroenterology and Hepatology suggests prehospitalization Proton Pump Inhibitor (PPI) exposure...
Human Gut Microbiome in COVID-19 - Exploring the Therapeutic Potential of Probiotics Hina Zahid6 Nov 2020 11:45 AM ISTThe ongoing COVID-19 pandemic has drastically changed the facets of biology, social interaction, and public health worldwide. It has had a deleterious...
Remdesivir, hydroxychloroquine, lopinavir/ritonavir, and Interferon used for treating COVID-19 not quite effective: Solidarity Trial Medical Dialogues Bureau16 Oct 2020 12:45 PM ISTUSA: Four re-purposed antiviral drugs including remdesivir, hydroxychloroquine, lopinavir/ritonavir, and Interferon-β1a used for the treatment of...
